Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Otsuka Pharmaceutical, Taiho Pharmaceutical patent PTPN11 inhibitors

March 17, 2021

AB-205 eliminates oral and gastrointestinal SRRT in adults undergoing HDT-AHCT

March 17, 2021

Immune system, treatment, in kidney cancer

March 17, 2021

In vitro and in vivo evaluation of quinazolinone derivative HoLu-12 for oral squamous cell carcinoma

March 16, 2021

NLRP3 inflammasome inhibitors patented by Inflazome

March 16, 2021

Polycomb protein EED inhibitors identified at Shanghai Blueray Biopharma

March 16, 2021

Shanghai Zhimeng Biopharma discovers Toll-like receptor 8 agonists

March 16, 2021

NSD3 drives oncogenesis in LUSC, but may sensitize these tumors to bromodomain inhibition

March 15, 2021

IFN-mediated NAD depletion by upregulation of PARP9/10/14 sensitizes PDAC cells to NAMPT inhibitors

March 15, 2021

Galapagos presents TYK2 inhibitors

March 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...